News for 'Central Drugs Laboratory'

Karnataka, Gujarat lift ban on Maggi

Karnataka, Gujarat lift ban on Maggi

Rediff.com19 Oct 2015

The state government had in the first week of June banned Maggi sale in the state after the product failed the food safety test.

Nawab Malik's Daughter Speaks Out!

Nawab Malik's Daughter Speaks Out!

Rediff.com28 Mar 2022

'Once you are in their system, they finish you with the never-ending processes.' 'Once your family member is arrested, you are just running between lawyers, courts and the jail.' 'The process to prove that you are innocent drains you to such an extent that you are finished.'

India eyes oil-for-drugs deal with Venezuela to recoup pharma cash

India eyes oil-for-drugs deal with Venezuela to recoup pharma cash

Rediff.com18 May 2016

Like pharmaceutical companies globally - which used to enjoy a preferential exchange rate in Venezuela - Indian producers have been left badly stung by the collapse of the bolivar currency

Ranbaxy gets FDA nod for Fluconazole tablets

Ranbaxy gets FDA nod for Fluconazole tablets

Rediff.com6 May 2003

Ranbaxy Laboratories has received tentative approval form the Food & Drug Administration USA for manufacturing and marketing Fluconazole tablets

Test to catch THG cheats out

Test to catch THG cheats out

Rediff.com22 Oct 2003

The method for detecting the new designer steroid is being sent to IOC-accredited laboratories throughout the world.\n\n

Now, UP FDA finds lead in ITC's Yippee noodles

Now, UP FDA finds lead in ITC's Yippee noodles

Rediff.com24 Aug 2015

Uttar Pradesh Food and Drug Authority (FDA) says it has found excess lead in the Yippee noodles of domestic giant ITC.

We could've seen 8.2L COVID-19 cases sans lockdown: Health min

We could've seen 8.2L COVID-19 cases sans lockdown: Health min

Rediff.com11 Apr 2020

Addressing a press briefing, Health Ministry's Joint Secretary Lav Agarwal said the government has taken early preemptive action to identify COVID-19 hotspots in the country.

HC grants Pfizer temporary relief on cough syrup ban

HC grants Pfizer temporary relief on cough syrup ban

Rediff.com15 Mar 2016

The next hearing on Pfizer's plea is slated for March 21

'My time in jail scarred me forever'

'My time in jail scarred me forever'

Rediff.com7 Apr 2022

'Your faith in the system, and in the fact that you are a citizen of this country and have rights, starts eroding.'

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Rediff.com6 Aug 2021

While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up very rapidly, reports Sohini Das.

Mumbai to build Wuhan-like hospital to treat COVID-19 patients

Mumbai to build Wuhan-like hospital to treat COVID-19 patients

Rediff.com7 May 2020

The hospital, in the commercial hub of Bandra-Kurla Complex, will serve as an isolation facility for non-critical COVID-19 patients. Expected to be ready in a fortnight, the new makeshift facility can be scaled up to 5,000 beds, if needed. The Brihanmumbai Municipal Corporation will run the hospital that will have, among other things, oxygen facilities and pathological laboratories. Sohini Das reports.

What I learnt from the COVID-19 Crisis

What I learnt from the COVID-19 Crisis

Rediff.com25 Jul 2020

'We are a country of amazing ability and the way we have responded to the pandemic is evidence.'

Human trials of Covaxin set to begin at AIIMS, Odisha institute

Human trials of Covaxin set to begin at AIIMS, Odisha institute

Rediff.com20 Jul 2020

AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting Phase I and II randomised, double-blind and placebo-controlled clinical trials of Covaxin.

FSSAI-approved lab finds Maggi noodles safe

FSSAI-approved lab finds Maggi noodles safe

Rediff.com4 Aug 2015

Many countries found Maggi noodles to be safe for consumption.

Gujarat pharma hub hit by near-zero exports

Gujarat pharma hub hit by near-zero exports

Rediff.com15 Apr 2020

With the government asking the companies to operate with only 50 per cent staff strength, and exports dipping to almost zero, the truck and bus drivers idling at the petrol pump say they hardly have any work now. At a petrol pump on the deserted Bavla-Changodar highway near Ahmedabad in Gujarat, several trucks and buses are neatly parked in a row.

40 lakh kept under surveillance for Covid contact-tracing: Govt

40 lakh kept under surveillance for Covid contact-tracing: Govt

Rediff.com15 Sep 2020

More than 30 vaccine candidates have been supported and they are in different stages of development. Three candidates are in advanced stage of Phase I, II and III trials, and more than four are in advanced pre-clinical development stage, Choubey said.

Sun, Ranbaxy may be asked to sell some businesses for CCI approval to merger

Sun, Ranbaxy may be asked to sell some businesses for CCI approval to merger

Rediff.com15 Oct 2014

A source said the competition watchdog would by next month suggest 'structural remedies' that included selling key drug segments as conditions for clearing the country's largest pharmaceutical industry merger.

Sunanda death due to poisoning, doctors say in fresh report

Sunanda death due to poisoning, doctors say in fresh report

Rediff.com9 Oct 2014

A team of AIIMS doctors has submitted a fresh report to police on the mysterious death of Sunanda Pushkar, wife of former Union minister Shashi Tharoor, maintaining that she died of poisoning.

Nifty ends above 8,700 at fresh 52-week closing high; RBI policy eyed

Nifty ends above 8,700 at fresh 52-week closing high; RBI policy eyed

Rediff.com8 Aug 2016

Gains were led by index heavyweights with Reliance Industries contributing the most.

No reason to hide Covid deaths; effort is to vaccinate all at earliest: Health Minister

No reason to hide Covid deaths; effort is to vaccinate all at earliest: Health Minister

Rediff.com20 Jul 2021

Replying to a short duration discussion on COVID-19 management in Rajya Sabha, the minister said technology transfer to several companies has started and they will begin production in the coming days to reduce vaccine shortage in the country.

Indians far from achieving herd immunity against COVID-19: Vardhan

Indians far from achieving herd immunity against COVID-19: Vardhan

Rediff.com27 Sep 2020

Vardhan said the ICMR is actively researching on reports of COVID-19 reinfection and although the number of such cases is negligible at this moment, the government is fully seized of the importance of the matter, the health ministry said in a statement.

Will bring India's Covid mortality rate to below 1 pc: Vardhan

Will bring India's Covid mortality rate to below 1 pc: Vardhan

Rediff.com17 Sep 2020

Union Health Minister Harsh Vardhan on Thursday said the government was aiming to bring down India's Covid-19 mortality rate to less than 1 per cent from the current 1.64 per cent, which is still the lowest in the world.

Stocks You Must AVOID or EXIT

Stocks You Must AVOID or EXIT

Rediff.com26 Apr 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

iGenetic Diagnostics: The next generation pathology lab

iGenetic Diagnostics: The next generation pathology lab

Rediff.com12 Apr 2017

When Prashanth Reddy's father was in an ICU he could not find a lab that would deliver a blood infection test report in 24 hours. That's where iGenetic Diagnostics, which uses molecular techniques next generation sequencing, came in.

Noodle crisis: Labelling dispute lands Nestle in hot water

Noodle crisis: Labelling dispute lands Nestle in hot water

Rediff.com9 Jun 2015

Nestle now has less than two weeks to convince the regulator why product approval for its noodles should not be withdrawn

Sensex, Nifty lose their way, end on a negative note

Sensex, Nifty lose their way, end on a negative note

Rediff.com2 Nov 2017

A widening probe by US authorities involving top drug companies following complaints of price fixing of generics was a point of worry for the participants, said analysts.

Selective relaxation in non-containment areas from April 20

Selective relaxation in non-containment areas from April 20

Rediff.com19 Apr 2020

The joint secretary also said a high-level task force to work on frontiers of science related to vaccines and drug testing was formed on Sunday.

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Rediff.com13 May 2021

The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.

Now, Goa bans sale of Maggi; 11th state to ban noodle brand

Now, Goa bans sale of Maggi; 11th state to ban noodle brand

Rediff.com7 Jun 2015

Goa on Sunday joined several other states in banning the sale of Nestle's instant noodle brand 'Maggi' which is at the centre of a raging nationwide row over food safety concerns.

Sun-Ranbaxy deal stirs monopoly concerns: CCI

Sun-Ranbaxy deal stirs monopoly concerns: CCI

Rediff.com30 Aug 2014

Competition watchdog says 'high market concentration' in some segments a worry.

New medical reports confirm 5 more rapes at Bihar shelter home

New medical reports confirm 5 more rapes at Bihar shelter home

Rediff.com29 Jul 2018

The CBI has booked officers and employees of the shelter home.

After Delhi, Maggi banned in 4 more states: U'khand, Gujarat, J&K, TN

After Delhi, Maggi banned in 4 more states: U'khand, Gujarat, J&K, TN

Rediff.com4 Jun 2015

After Delhi, four more states -- Gujarat, Tamil Nadu, Jammu and Kashmir and Uttarakhand - on Thursday banned the sale of Maggi noodles, as the popular instant snack came under mounting scrutiny over food safety concerns.

When should you take Covishield/Covaxin?

When should you take Covishield/Covaxin?

Rediff.com26 Mar 2021

'You can still acquire the COVID-19 virus even if you are vaccinated.' 'But if you develop the disease, (after being vaccinated) the likelihood is that it will be mild.' 'It just makes sense to continue to take precautions, because you may be around a lot of unvaccinated people.'

Markets ends flat; Sensex posts best monthly gain in over 4 years

Markets ends flat; Sensex posts best monthly gain in over 4 years

Rediff.com31 Mar 2016

The S&P BSE Sensex ended the session at 25,342, up 3 points while the Nifty50 closed at 7,738 points.

Peaceful and secure neighbourhood will yield 'rich dividends' for SAARC, says India

Peaceful and secure neighbourhood will yield 'rich dividends' for SAARC, says India

Rediff.com16 Mar 2016

India said it firmly believes that a peaceful and secure neighbourhood will yield "rich dividends" for SAARC nations.

Global meltdown, oil woes drag Sensex 239 points lower; FOMC eyed

Global meltdown, oil woes drag Sensex 239 points lower; FOMC eyed

Rediff.com13 Jun 2016

Sharp fall in capital goods production and manufacturing activity also dented sentiments.

Noodle bar? Centre steps in as food regulators ask all states to test Maggi

Noodle bar? Centre steps in as food regulators ask all states to test Maggi

Rediff.com3 Jun 2015

The trouble for Nestle's Maggi started in Uttar Pradesh last month and has now spread nationwide. The Food and Drug Administration has directed all states on Wednesday to get sample of India's most popular instant noodles tested for high content of lead and mono-sodium glutamate, a taste enhancer.

Sheena murder: CBI raids 9 locations; Indrani's custody extended

Sheena murder: CBI raids 9 locations; Indrani's custody extended

Rediff.com19 Oct 2015

CBI sources said that agency teams swooped down at the residences of Peter and Indrani, two each in Mumbai and Goa, Indrani's ancestral home in Guwahati, her driver Shyamvar Pinturam Rai's houses in Mumbai and Chhindwara, Madhya Pradesh, and the residence of Sanjeev Khanna in Kolkata.

With 2 more Covid deaths, nationwide toll reaches 9; total cases 468

With 2 more Covid deaths, nationwide toll reaches 9; total cases 468

Rediff.com23 Mar 2020

The Union health ministry said West Bengal and Himachal Pradesh reported a casualty each on Monday, taking the total number of deaths to nine in the country due to COVID-19.

Sensex ends lower in lacklustre trade

Sensex ends lower in lacklustre trade

Rediff.com1 Feb 2016

The S&P BSE Sensex ended 46 points lower at 24,824 and Nifty50 settled at 7,555, down by 8 points after hitting intra-day high of 7,600.45.